Drug developer Axovant's CEO, COO step down

Feb 12 (Reuters) - Axovant Sciences Ltd on Monday said Chief Executive Officer David Hung had resigned, nearly a year after his appointment.

Chief Operating Officer Marion McCourt has also stepped down, along with three members of the drug developer's board.

The company named Pavan Cheruvu as its new CEO. (Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)